ES552805A0 - Un metodo para preparar un compuesto quimico, inhibidor de las 5-lipoxigenasas,util para la terapia humana y veterinaria - Google Patents
Un metodo para preparar un compuesto quimico, inhibidor de las 5-lipoxigenasas,util para la terapia humana y veterinariaInfo
- Publication number
- ES552805A0 ES552805A0 ES552805A ES552805A ES552805A0 ES 552805 A0 ES552805 A0 ES 552805A0 ES 552805 A ES552805 A ES 552805A ES 552805 A ES552805 A ES 552805A ES 552805 A0 ES552805 A0 ES 552805A0
- Authority
- ES
- Spain
- Prior art keywords
- lipoxigenases
- inhibitor
- preparing
- human
- useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
- C07D213/34—Sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB858506094A GB8506094D0 (en) | 1985-03-08 | 1985-03-08 | Chemical products |
| GB858525153A GB8525153D0 (en) | 1985-10-11 | 1985-10-11 | Chemical compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8802610A1 ES8802610A1 (es) | 1988-09-16 |
| ES552805A0 true ES552805A0 (es) | 1988-09-16 |
Family
ID=26288945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES552805A Expired ES8802610A1 (es) | 1985-03-08 | 1986-03-07 | Un metodo para preparar un compuesto quimico, inhibidor de las 5-lipoxigenasas,util para la terapia humana y veterinaria |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US4826987A (es) |
| JP (1) | JPH0764813B2 (es) |
| AU (1) | AU585586B2 (es) |
| BE (1) | BE904368A (es) |
| CA (1) | CA1276640C (es) |
| DE (1) | DE3607382A1 (es) |
| DK (1) | DK166582B1 (es) |
| ES (1) | ES8802610A1 (es) |
| FR (1) | FR2578540B1 (es) |
| GB (1) | GB2173788B (es) |
| GR (1) | GR860628B (es) |
| IE (1) | IE58870B1 (es) |
| IT (1) | IT1221079B (es) |
| LU (1) | LU86349A1 (es) |
| NL (1) | NL8600596A (es) |
| NZ (1) | NZ215347A (es) |
| PT (1) | PT82147B (es) |
| SE (1) | SE463819B (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE68789T1 (de) * | 1985-10-16 | 1991-11-15 | Merck Frosst Canada Inc | 2-substituierte chinoline. |
| DK196688A (da) * | 1987-04-28 | 1988-10-29 | Fujisawa Pharmaceutical Co | Bicykliske forbindelser og fremgangsmaade til fremstilling deraf |
| US4826990A (en) * | 1987-09-30 | 1989-05-02 | American Home Products Corporation | 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents |
| GB8728051D0 (en) * | 1987-12-01 | 1988-01-06 | Leo Pharm Prod Ltd | Chemical compounds |
| US4889935A (en) * | 1987-12-18 | 1989-12-26 | American Home Products Corporation | Aminoguanidine derivatives |
| WO1990012006A1 (en) * | 1989-04-07 | 1990-10-18 | Pfizer Inc. | Substituted 1-[3-(heteroarylmethoxy)phenyl]alkanols and related compounds in the treatment of asthma, arthritis and related diseases |
| DE3927369A1 (de) * | 1989-08-19 | 1991-02-21 | Bayer Ag | Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe |
| DE3935139A1 (de) * | 1989-10-21 | 1991-04-25 | Bayer Ag | Substituierte (chinolin-2-yl-methoxy)phenyl-thioharnstoffe |
| US5021576A (en) * | 1989-10-27 | 1991-06-04 | American Home Products Corporation | 2-Anilino phenylacetic acid derivatives |
| US5324747A (en) * | 1992-07-15 | 1994-06-28 | Hoffmann-La Roche Inc. | N-substituted anilines, inhibitors of phospholipases A2 |
| US5840318A (en) * | 1993-05-11 | 1998-11-24 | Immunom Technologies, Inc. | Methods and compositions for modulating immune systems of animals |
| US7189834B2 (en) * | 1993-05-11 | 2007-03-13 | Marshall William E | Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection |
| US5508408A (en) * | 1993-09-10 | 1996-04-16 | Ciba-Geigy Corporation | Quinoline compound |
| US5795900A (en) * | 1995-10-03 | 1998-08-18 | Abbott Laboratories | Symmetrical bis-heteroaryl-methoxy-phenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
| US5668150A (en) * | 1996-07-26 | 1997-09-16 | Abbott Laboratories | Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
| AU754965B2 (en) * | 1997-12-31 | 2002-11-28 | University Of Kansas, The | Water soluble prodrugs of tertiary amine containing drugs and methods of making thereof |
| HN2001000008A (es) | 2000-01-21 | 2003-12-11 | Inc Agouron Pharmaceuticals | Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo |
| US8399666B2 (en) * | 2005-11-04 | 2013-03-19 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
| US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
| GB2431927B (en) * | 2005-11-04 | 2010-03-17 | Amira Pharmaceuticals Inc | 5-Lipoxygenase-activating protein (FLAP) inhibitors |
| TW200920369A (en) * | 2007-10-26 | 2009-05-16 | Amira Pharmaceuticals Inc | 5-lipoxygenase activating protein (flap) inhibitor |
| MX2010012814A (es) * | 2008-05-23 | 2010-12-20 | Amira Pharmaceuticals Inc | Inhibidor de proteina activadora de 5-lipoxigenasa. |
| US8546431B2 (en) | 2008-10-01 | 2013-10-01 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
| TW201215607A (en) | 2010-07-02 | 2012-04-16 | Lundbeck & Co As H | Aryl-and heteroarylamid derivatives as PDE10A enzyme inhibitor |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US31624A (en) * | 1861-03-05 | Tatting-frame | ||
| US2761865A (en) * | 1954-07-07 | 1956-09-04 | Hoffmann La Roche | Pyridylalkyl sulfones |
| US4003906A (en) * | 1974-01-22 | 1977-01-18 | The Dow Chemical Company | Substituted pyridinyl methylthio or (methylsulfonyl)benzeneamines |
| GB2069493B (en) * | 1980-02-20 | 1984-02-29 | Wyeth John & Brother Ltd | Pyridine derivatives |
| GB2069492B (en) * | 1980-02-20 | 1984-02-29 | Wyeth John & Brother Ltd | Sulphur compounds |
| US4567184A (en) * | 1982-12-01 | 1986-01-28 | Usv Pharmaceutical Corporation | Certain aryl or hetero-aryl derivatives of 1-hydroxy-pentane or 1-hydroxy-hexane which are useful for treating inflammation and allergies |
| IE56702B1 (en) * | 1982-12-01 | 1991-11-06 | Usv Pharma Corp | Antiinflammatory antiallergic compounds |
| JPS5988835U (ja) * | 1982-12-06 | 1984-06-15 | ホシデン株式会社 | スイツチ |
| US4486593A (en) * | 1983-01-19 | 1984-12-04 | The Upjohn Company | 2-,3-, or 4-Pyridinylmethylamino arylic acids as thromboxane A2 synthetase and 5-lipoxygenase inhibitors |
| US4563463A (en) * | 1983-03-18 | 1986-01-07 | Usv Pharmaceutical Corp. | 2-Oxo-1,3-oxazolo[4,5-h] quinolines useful as anti-allergy agents |
| US4554355A (en) * | 1984-07-19 | 1985-11-19 | American Home Products Corporation | Heterocyclic compounds as antiallergic agents |
| US5109009A (en) * | 1985-03-08 | 1992-04-28 | Leo Pharmaceutical Products Ltd. | Quinoline and pyridine compounds and inhibition of 5-lipoxygenases therewith |
-
1986
- 1986-02-10 IE IE37086A patent/IE58870B1/en not_active IP Right Cessation
- 1986-02-20 GB GB08604183A patent/GB2173788B/en not_active Expired
- 1986-02-28 US US06/834,542 patent/US4826987A/en not_active Expired - Fee Related
- 1986-02-28 SE SE8600913A patent/SE463819B/sv not_active IP Right Cessation
- 1986-03-03 NZ NZ215347A patent/NZ215347A/xx unknown
- 1986-03-04 DK DK096986A patent/DK166582B1/da not_active IP Right Cessation
- 1986-03-06 GR GR860628A patent/GR860628B/el unknown
- 1986-03-06 DE DE19863607382 patent/DE3607382A1/de not_active Ceased
- 1986-03-06 PT PT82147A patent/PT82147B/pt not_active IP Right Cessation
- 1986-03-06 IT IT67183/86A patent/IT1221079B/it active
- 1986-03-06 CA CA000503464A patent/CA1276640C/en not_active Expired - Lifetime
- 1986-03-07 BE BE0/216378A patent/BE904368A/fr not_active IP Right Cessation
- 1986-03-07 AU AU54444/86A patent/AU585586B2/en not_active Ceased
- 1986-03-07 LU LU86349A patent/LU86349A1/fr unknown
- 1986-03-07 FR FR868603268A patent/FR2578540B1/fr not_active Expired - Lifetime
- 1986-03-07 NL NL8600596A patent/NL8600596A/nl not_active Application Discontinuation
- 1986-03-07 ES ES552805A patent/ES8802610A1/es not_active Expired
- 1986-03-08 JP JP61051286A patent/JPH0764813B2/ja not_active Expired - Lifetime
-
1990
- 1990-12-31 US US07/633,390 patent/US5157039A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US4826987A (en) | 1989-05-02 |
| NL8600596A (nl) | 1986-10-01 |
| ES8802610A1 (es) | 1988-09-16 |
| SE463819B (sv) | 1991-01-28 |
| FR2578540B1 (fr) | 1990-11-16 |
| PT82147B (pt) | 1988-07-29 |
| AU5444486A (en) | 1986-09-18 |
| IE58870B1 (en) | 1993-11-17 |
| US5157039A (en) | 1992-10-20 |
| FR2578540A1 (fr) | 1986-09-12 |
| NZ215347A (en) | 1990-02-26 |
| DK166582B1 (da) | 1993-06-14 |
| AU585586B2 (en) | 1989-06-22 |
| IE860370L (en) | 1986-09-08 |
| DK96986D0 (da) | 1986-03-04 |
| DE3607382A1 (de) | 1986-09-11 |
| BE904368A (fr) | 1986-09-08 |
| PT82147A (en) | 1986-04-01 |
| JPH0764813B2 (ja) | 1995-07-12 |
| GR860628B (en) | 1986-06-26 |
| IT8667183A0 (it) | 1986-03-06 |
| JPS61207374A (ja) | 1986-09-13 |
| DK96986A (da) | 1986-09-09 |
| GB8604183D0 (en) | 1986-03-26 |
| GB2173788A (en) | 1986-10-22 |
| GB2173788B (en) | 1988-08-10 |
| SE8600913D0 (sv) | 1986-02-28 |
| IT1221079B (it) | 1990-06-21 |
| LU86349A1 (fr) | 1987-04-02 |
| SE8600913L (sv) | 1986-09-09 |
| CA1276640C (en) | 1990-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES552805A0 (es) | Un metodo para preparar un compuesto quimico, inhibidor de las 5-lipoxigenasas,util para la terapia humana y veterinaria | |
| ES550986A0 (es) | Un metodo para preparar un derivadode tiazolidin-diona | |
| ES552432A0 (es) | Procedimiento para preparar derivados de urea | |
| PT80237B (pt) | Processo para a metilacao selectiva de derivados de eritromicina a | |
| ES555014A0 (es) | Un metodo para producir nuevos derivados del acido ascorbico | |
| BR8602834A (pt) | Metodo e aparelho para expandir tabaco | |
| PT82769B (pt) | Processo para a preparacao de derivados de acidos tiazolidino-4(s)-caboxilicos | |
| ES555646A0 (es) | Un procedimiento para producir derivados de 4-0-sulfonil-uracilo | |
| ES556026A0 (es) | Un procedimiento para preparar derivados de tienopiridona | |
| ES557395A0 (es) | Un procedimiento para preparar derivados arilicos de dienamidas | |
| MX163665B (es) | Metodo para producir vaciados metalicos | |
| ES553447A0 (es) | Procedimiento para la obtencion de nuevas benzamidas | |
| ES556306A0 (es) | Procedimiento para preparar laminina humana | |
| IS3082A7 (is) | Aðferð til að verka fisk | |
| KR870700592A (ko) | 치환벤즈 알데히드의 제조방법 | |
| ES553644A0 (es) | Un metodo para preparar renina humana. | |
| ES552205A0 (es) | Metodo para la fabricacion de calzado | |
| BR8702357A (pt) | Metodo para realizacao de processos endotermicos | |
| RO92640A2 (ro) | Metoda pentru tratamentul keratitelor virotice | |
| IT8612467A0 (it) | Metodo per la fabbricazione di un dispositivo di tagliatura e dispositivo cosi ottenuto | |
| RO91766A2 (ro) | Metoda de tratament a enterobiozei | |
| ES550147A0 (es) | Procedimiento para la obtencion de acido miristico | |
| ZW24386A1 (en) | A method of processing animal flesh | |
| ES550772A0 (es) | Procedimiento para preparar piensos para animales | |
| ES544816A0 (es) | Procedimiento de obtencion de un derivado de la guanidina deintereses terapeutico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19990405 |